Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety Study of LRYGB to Treat Type 2 Diabetes Mellitus

NCT01277900 is registered in ClinicalTrials.gov with Asia Metabolic Surgery Research Group as lead sponsor.

NCT NCT01277900
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01277900 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety Study of LRYGB to Treat Type 2 Diabetes Mellitus
Lead sponsor
Asia Metabolic Surgery Research Group
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2011
Completion date
December 31, 2013
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus - poor control